109 related articles for article (PubMed ID: 24578007)
1. Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer.
Higashi K; Ueda Y; Sakurai A; Mingwang X; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 24578007
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Glut-1 glucose transporter expression with.
Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
[TBL] [Abstract][Full Text] [Related]
3. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
Choi WH; Yoo IeR; O JH; Kim TJ; Lee KY; Kim YK
Technol Health Care; 2015; 23 Suppl 2():S311-8. PubMed ID: 26410497
[TBL] [Abstract][Full Text] [Related]
4. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
[TBL] [Abstract][Full Text] [Related]
6. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
[TBL] [Abstract][Full Text] [Related]
7. Biological correlates of FDG uptake in non-small cell lung cancer.
de Geus-Oei LF; van Krieken JH; Aliredjo RP; Krabbe PF; Frielink C; Verhagen AF; Boerman OC; Oyen WJ
Lung Cancer; 2007 Jan; 55(1):79-87. PubMed ID: 17046099
[TBL] [Abstract][Full Text] [Related]
8. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown RS; Leung JY; Kison PV; Zasadny KR; Flint A; Wahl RL
J Nucl Med; 1999 Apr; 40(4):556-65. PubMed ID: 10210213
[TBL] [Abstract][Full Text] [Related]
9. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
Higashi K; Ueda Y; Ikeda R; Kodama Y; Guo J; Matsunari I; Oguchi M; Tonami H; Katsuda S; Yamamoto I
Nucl Med Commun; 2004 Jan; 25(1):19-27. PubMed ID: 15061261
[TBL] [Abstract][Full Text] [Related]
11. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract][Full Text] [Related]
12. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
[TBL] [Abstract][Full Text] [Related]
13. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
[TBL] [Abstract][Full Text] [Related]
15. [The Correlation between FDG PET/CT Imaging and Molecule Makers in Non-Small Cell Lung Cancer.].
Zhou M; Sun T; Xing X; Yang J
Zhongguo Fei Ai Za Zhi; 2009 Feb; 12(2):172-5. PubMed ID: 20716415
[TBL] [Abstract][Full Text] [Related]
16. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
[TBL] [Abstract][Full Text] [Related]
17. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Higashi T; Tamaki N; Honda T; Torizuka T; Kimura T; Inokuma T; Ohshio G; Hosotani R; Imamura M; Konishi J
J Nucl Med; 1997 Sep; 38(9):1337-44. PubMed ID: 9293783
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
19. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
[TBL] [Abstract][Full Text] [Related]
20. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
